EUVIMEDEUVIMED entdecken
Fallbericht

Peri‐implant medication‐related osteonecrosis of the jaw mimicking endodontic disease in a cancer patient: A case report

André Caroli Rocha iD, Maria Emília Mota iD, Ricardo Costa Lima iD, Nayara Fernanda Pereira iD, Fabio Abreu Alves iD, Maria Stella Moreira iD

Australian Endodontic Journal · 2024

DOI: 10.1111/aej.12893 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Australian Endodontic Journal, 2024. Verfasst von André Caroli Rocha und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral Medicine, A.C. Camargo Cancer Center, São Paulo, Brazil. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Zoledronic Acid. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medication‐related osteonecrosis of the jaw (MRONJ) is a progressive condition that can cause significant bone loss and its diagnosis can be challenging. A 68‐year‐old man with a diagnosis of hepatocellular carcinoma, undergoing treatment with atezolizumab, bevacizumab and zoledronic acid, complained of spontaneous pain in the right lower second premolar. Oral examination revealed no dental changes and implants in the right jaw. A patient history and thorough clinical and radiographic examinations mimic endodontic disease. The implant crowns were removed, bleeding on probing, and peri‐implant pockets were observed. The main hypothesis was MRONJ Stage 2, and the surgical treatment was performed. The pain ceased and signs of MRONJ were not observed within 3 months. MRONJ should be considered as a hypothesis in the case of odontalgia and a patient's history of antiresorptive and antiangiogenic therapies. Furthermore, monitoring patients with dental implants in the mandible through detailed clinical and imaging evaluation is required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bisphosphonate-Associated Osteonecrosis of the JawZoledronic AcidHumansMaleAgedDiagnosis, DifferentialDental ImplantsLiver NeoplasmsBevacizumabBone Density Conservation Agents

Stichwörter der Autor:innen

dental pulp diseasesendodontic diseasesmedication‐related osteonecrosis of the jawosteonecrosisprecision dentistry

Substanzen

Zoledronic AcidDental ImplantsBevacizumabBone Density Conservation Agents

Autor:innen und Institutionen

  • Department of Oral Medicine, A.C. Camargo Cancer Center, São Paulo, Brazil.
  • Department of Dentistry, Clinics Hospital, University of São Paulo, São Paulo, Brazil.
  • Department of Stomatology, School of Dentistry, University of São Paulo (USP), São Paulo, Brazil.
  • Department of Hospital Dentistry, Hospital Paulistano, São Paulo, Brazil.

ORCID-Profile: André Caroli Rocha, Maria Emília Mota, Ricardo Costa Lima, Nayara Fernanda Pereira, Fabio Abreu Alves, Maria Stella Moreira

Zitieren

APA

Rocha, A. C., Mota, M. E., Lima, R. C., Pereira, N. F., Alves, F. A., & Moreira, M. S. (2024). Peri‐implant medication‐related osteonecrosis of the jaw mimicking endodontic disease in a cancer patient: A case report. Australian Endodontic Journal. https://doi.org/10.1111/aej.12893

Vancouver

Rocha AC, Mota ME, Lima RC, Pereira NF, Alves FA, Moreira MS. Peri‐implant medication‐related osteonecrosis of the jaw mimicking endodontic disease in a cancer patient: A case report. Australian Endodontic Journal. 2024. doi:10.1111/aej.12893

BibTeX
@article{Rocha2024,
  author = {Rocha, André Caroli and Mota, Maria Emília and Lima, Ricardo Costa and Pereira, Nayara Fernanda and Alves, Fabio Abreu and Moreira, Maria Stella},
  title = {Peri‐implant medication‐related osteonecrosis of the jaw mimicking endodontic disease in a cancer patient: A case report},
  journal = {Australian Endodontic Journal},
  year = {2024},
  doi = {10.1111/aej.12893}
}
Kostenlos starten →